Culture, Media and Sport

British Film Institute

Stella Creasy: To ask the Secretary of State for Culture, Media and Sport with reference to the recommendation of the Common Best Practice Code published by the Department for Business, Innovation and Skills jointly with the Arts Council that interns should be paid at least the minimum wage, what assessment she has made of the recent advertisement by her Department's arm's length body the British Film Institute for 18 unpaid interns. [142813]

Mr Vaizey [holding answer 11 February 2013]: As a registered charity and under current guidelines, the BFI is able to offer internship/work experience opportunities on a voluntary basis. These placements offer managed work experience across a wide range of departments, including archive, library, charitable fundraising and audience development.

In light of the recommendations of the Common Best Practice Code published by the Department for Business, Innovation and Skills jointly with the Arts Council, the BFI is currently considering the future of the scheme.

Broadband: Rural Areas

Mr Jamie Reed: To ask the Secretary of State for Culture, Media and Sport pursuant to the answer of 22 January 2013, Official Report, column 234W, on broadband: rural areas, what steps her Department is taking to improve broadband access for people in rural dwellings. [142335]

Mr Vaizey [holding answer 11 February 2013]: £530 million of the Government's total of £680 million has been made available to projects covering rural areas. The programme continues to move at pace. A total of 11 local projects have now signed contracts, and are either in delivery or about to commence. The remainder should have completed their procurements by this summer. Complementary to the wider rural broadband programme, the Rural Community Broadband Fund, jointly funded by DEFRA and Broadband Delivery UK (BDUK), is aimed at improving access to broadband for the hardest to reach rural areas and communities.

Film

Dan Jarvis: To ask the Secretary of State for Culture, Media and Sport how many UK feature films were produced in (a) 2008, (b) 2009, (c) 2010, (d) 2011 and (e) the latest period for which figures are available. [142356]

Mr Vaizey: The UK is feeling the reverberations of a slow-down in film production globally and film budgets have tightened in response to international market forces. However, we have seen significant private sector investment in facilities such as Warner Bros £100 million commitment to Leavesden, and Elstree Studios and Pinewood Studios are both seeking to expand capacity. Last October, Disney announced that it is to create a permanent base at Pinewood Studios. All of this underlines the long-term confidence in the UK film production sector.

Number of features produced in the UK, 2008-12
 20082009201020112012

Co-productions

29

37

31

47

38

Domestic UK features

227

251

293

238

159

Of which:

     

Budgets >=£500,000

83

88

79

82

65

Of which:

     

Budgets <£500,000

144

163

214

156

94

      

Inward investment feature films

31

37

29

34

26

Total

287

325

353

319

223

Notes: 1. Data are rounded to the nearest £0.1 million so may not sum exactly to the totals shown. 2. Films are allocated to the calendar year in which principal photography commenced. 3. Films at all budget levels are included in this analysis. For pre-2008 data restricted to films with budgets >=£500,000 see the BFI 2012 Statistical Yearbook: www.bfi.org.uk/statisticalyearbook2012 Source: BFI

Local Press

Mr Jim Cunningham: To ask the Secretary of State for Culture, Media and Sport what steps the Government are taking to promote local journalism and to protect local newspapers. [142995]

Mr Vaizey: The Government are aware of the cyclical and structural economic challenges facing the traditional print press, and that these challenges are intensified for our local and regional newspapers.

The Government are working with industry to ensure that the voice of local newspapers is heard in the discussions currently taking place around implementation of Leveson’s recommendations.

The Government took action last year to relax cross-media ownership rules, which now make it easier for local media owners to purchase media businesses across formats. Zero-rated VAT also continues to apply to newspapers.

12 Feb 2013 : Column 659W

Local Press: West Midlands

Mr Jim Cunningham: To ask the Secretary of State for Culture, Media and Sport what recent assessment she has made of the strength of local journalism in the West Midlands. [142996]

Mr Vaizey: No assessment has been made of the strength of local journalism in the West Midlands.

Trinity Mirror

Mr Jim Cunningham: To ask the Secretary of State for Culture, Media and Sport whether she has had any discussions with representatives from Trinity Mirror plc regarding its latest job loss proposals. [142993]

Mr Vaizey: No discussions have been held with representatives of Trinity Mirror plc regarding proposed changes to its publishing operations.

Mr Jim Cunningham: To ask the Secretary of State for Culture, Media and Sport what representations she has received on the recent proposals for job losses at Trinity Mirror plc and the potential effect of those proposals on local journalism. [142994]

12 Feb 2013 : Column 660W

Mr Vaizey: No representations have been received about Trinity Mirror's proposed changes to its publishing operations.

Health

Advisory Committee on Resource Allocation

Dr Thérèse Coffey: To ask the Secretary of State for Health pursuant to the answer of 4 February 2013, Official Report, columns 82-3W, on the Advisory Committee on Resource Allocation (ACRA), (1) what the names are of the current members of the ACRA; [142289]

(2) if he will publish the agenda, minutes and reports submitted for each of the meetings of the ACRA since May 2010; [142290]

(3) from which other Government Departments and devolved Administrations the civil servants on ACRA came; from which primary care trusts the GPs and NHS managers came; and from which organisations the public health consultants came. [142291]

Dr Poulter: The current members of the Advisory Committee on Research Allocation (ACRA) and its Technical Advisory Group (TAG) are shown as follows.

 NameACRATAG 

1

Mr David Fillingham (Chair ACRA)

Yes

Chief Executive, Advancing Quality Alliance (AQuA)

2

Mr Rob Webster (Chair TAG)

Yes

Yes

Chief Executive, Leeds Community Healthcare NHS Trust

3

Mr Sam Alderson

Yes

Civil Servant, Department of Health

4

Dr Chris Bentley

Yes

PH Consultant, HINST Associates

5

Professor Gwyn Bevan

Yes

Yes

Professor of Management Science, London School of Economics and Political Science

6

Mr Paul Brickwood

Yes

Director of Finance and Commissioning, Knowsley Primary Care Trust

7

Mr Mark Chandler

Yes

Civil Servant, Department of Health, Social Services & Public Safety (N Ireland)

8

(1)

Yes

Yes

Civil Servant, Department of Health

9

Mr Steve Clarke

Yes

Director of Finance, East of England Strategic Health Authority

10

Dr Mike D'Souza

Yes

General Practitioner, Kingston Multi-fund GP consortium (Former)

11

Mr Keith Derbyshire

Yes

Yes

Civil Servant, Department of Health

12

Dr Paul Edmondson-Jones MBE

Yes

Director of Public Health and Well-Being, City of York Council

13

Mr Jon Ford

Yes

Yes

Head of Health Policy and Economic Research, British Medical Association

14

(1)

Yes

Head of Health Analysis, Office for National Statistics

15

(1)

Yes

Senior Public Health Analyst, Department of Health

16

Dr Peter Holden

Yes

General Practitioner, British Medical Association (GP Committee)

17

Mr Ben Humberstone

Yes

Head of Population and Demography Division, Office for National Statistics

18

Professor Sir Brian Jarman

Yes

Emeritus Professor of Primary Care, Imperial College of Medicine

19

Professor Martin Knapp

Yes

Professor of Social Policy, London School of Economics and Political Science

20

Mr Andy Leary

(1)

Yes

Director of Finance, Leicester and Lincoln Local Area Team

21

Dr Stephen Lorrimer

Yes

Yes

Civil Servant, Department of Health

22

(1)

Yes

Civil Servant/Economic Advisor, Scottish Government

23

Ms Rhona MacDonald

Yes

Chief Executive (former), Bath and North Somerset Primary Care Trust

24

(1)

Yes

Civil Servant, Department of Health, Social Services & Public Safety (N Ireland)

25

Mrs Candy Morris

Yes

Chief Executive, South East Coast Strategic Health Authority

12 Feb 2013 : Column 661W

12 Feb 2013 : Column 662W

26

Professor Phil Rees

Yes

Emeritus Professor, University of Leeds

27

Mr David Reynolds

Yes

Director of Finance, Freeman Hospital

28

Professor Nigel Rice

Yes

Prof of Health Economics, The University of York, Centre for Health Economics

29

Mr Dave Roberts

Yes

Head of Primary Care Strategy, Health & Social Care Information Centre

30

Professor Colin Sanderson

Yes

Yes

Senior Lecturer, London School of Hygiene and Tropical Medicine

31

(1)

Yes

Yes

Civil Servant, Department of Health

32

(1)

Yes

Yes

Head of Population Dynamics, Office for National Statistics

33

Dr Ian Trimble

Yes

General Practitioner, Elmswood Surgery, Nottingham

34

Professor Margaret Whitehead

Yes

W.H. Duncan Chair of Public Health, The University of Liverpool

35

Professor Frank Windmeijer

Yes

Head of Department of Economics and Professor of Econometrics, University of Bristol

(1 )Names of the following senior civil servants or equivalent have been withheld. Dr Ruth Hussey from NHS North West, stepped down from ACRA in July 2012 and has now taken up the post of Chief Medical Officer for Wales. Mr Jeremy Taylor, Chief Executive of National Voices, a national coalition of health and social care charities in England, stepped down in April 2012.

The final recommendations of ACRA have been published on the Department's website at:

www.dh.gov.uk/health/2013/01/ph-grants-las/

Alongside this, we have published the nine most relevant research reports considered by ACRA, including responses to the public health engagement exercise. To retrieve, examine and redact the remaining papers would incur disproportionate cost.

Horsemeat

Mary Creagh: To ask the Secretary of State for Health when the Food Standards Agency (FSA) was alerted to suspect meat in a Freeza Meat Ltd storage warehouse; who alerted the FSA to the presence of the meat; what advice the FSA issued to the alerting authority; and what steps the FSA took with regard to the suspect meat. [142560]

Anna Soubry: On 4 February 2013, the Food Standards Agency (FSA) received results from samples taken by Newry and Mourne district council from the detained consignment. Of the 12 samples taken from the consignment, two tested positive for equine DNA at levels between 60% and 100%.

The consignment of meat believed to be destined for Silvercrest has been detained by Environmental Health officials in the cold store of Freeza Meats Ltd since October 2012. It was detained because of queries over the provenance of the product. The FSA has been working closely with the local authority throughout that investigation.

Following the publication of the Food Safety Authority of Ireland (FSAI) authenticity survey results, the FSA ascertained that the product stored in Freeza Meats was imported from the same Polish source involved in the FSAI's survey. As this meat was detained, none of this meat has been used as an ingredient in food that has entered the food chain.

Mary Creagh: To ask the Secretary of State for Health pursuant to the answer of 22 January 2013, Official Report, column 261W, on beef: horsemeat, if he intends that the 796 samples tested for meat identification in 2012 will be tested for the presence of horsemeat. [143058]

Anna Soubry: The samples taken by local authorities during 2012 would have been collected for a variety of reasons and subject to different handling procedures. After having been tested for meat identification they would have been dealt with in accordance with the analytical laboratory's standard procedures and in agreement with the local authority concerned. In the majority of cases the samples will have been destroyed, or it would not be appropriate to subject them to further analysis.

The Food Standards Agency has initiated a United Kingdom-wide targeted survey of the presence of undeclared horsemeat in processed meat available at retail, wholesale and catering businesses, and which follows set sampling and analytical protocols.

Carers: Travel

Ian Swales: To ask the Secretary of State for Health how much time, on average, carers spend travelling between house calls. [143003]

Norman Lamb: The information requested is not collected centrally.

On 18 September 2012, the Government launched the Developing Care Markets for Quality and Choice programme. This programme reinforces the commitment to driving up quality by enabling people to choose the services they receive. This follows a commitment in the White Paper to offer support to all local authorities to develop their market shaping capacity, and produce a high quality Market Position Statement. The tailored support provided through this programme, will encourage local authorities to commission more strategically.

We are ruling out crude 'contracting by the minute' that turns care workers into clock watchers and will work with commissioners, care providers, people who use the services, carers and the Think Local Act Personal partnership to bring an end to commissioning practices that undermine people's dignity and choice.

Christchurch Hospital

Mr Chope: To ask the Secretary of State for Health if he will place in the Library a copy of the independent expert opinion obtained by the Royal Bournemouth and Christchurch Hospitals Foundation Trust on the

12 Feb 2013 : Column 663W

cost benefit analysis of options for the future of the H block at Christchurch Hospital, including the option of demolition. [143021]

Anna Soubry: This is a matter for the Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust.

We have written to the Trust's chair, Jane Stichbury, informing her of your inquiries. She will reply shortly and a copy of the letter will be placed in the Library.

Conversion Therapy

Diana Johnson: To ask the Secretary of State for Health (1) if he will make it his policy to prohibit the commissioning of conversion therapy by (a) clinical commissioning groups, (b) GP commissioning and (c) the National Commissioning Board; [142816]

(2) what recent representations he has received on conversion therapy. [142817]

Norman Lamb: The Department does not recommend the use of conversion therapy and it is not a National Institute for Health and Clinical Excellence recommended treatment. I do not believe it would be appropriate to commission conversion therapy using public funds. It is for commissioners of NHS services to ensure that treatment and care, including therapy, is provided to every patient without any form of discrimination. Clinical commissioning groups (CCGs) will in future commission the majority of health care services. As public sector organisations, they will be subject to the specific duties of the public sector Equality Duty under the Equality Act 2010. Therefore CCGs must, in the exercise of their functions, have due regard to the need to eliminate unlawful discrimination, harassment and victimisation and other conduct prohibited under the Act.

We have had no other representations on this issue.

Dalepak

Mary Creagh: To ask the Secretary of State for Health pursuant to the answer of 22 January 2013, Official Report, column 266W, on Dalepak, how much was spent on (a) food hygiene inspection by Hambleton District Council on 25 June 2012 and (b) the meat composition and labelling inspection by North Yorkshire Trading Standards on 6 March 2012. [143059]

Anna Soubry: The Food Standards Agency does not hold data on the cost of food establishment inspections carried out by local authorities and is therefore unable to provide the requested information.

Defibrillators

Steve Rotheram: To ask the Secretary of State for Health how many defibrillators have been distributed by the National Defibrillator Programme to date; and how many schools have been provided with defibrillators under this programme. [142893]

Anna Soubry: Under the National Defibrillator Programme, 3,000 defibrillators were provided to national health service organisations that provide ambulance services, to place in the community. From February

12 Feb 2013 : Column 664W

2007, responsibility for sustaining the legacy of the National Defibrillator Programme was devolved to NHS ambulance trusts.

Depression

Chris Ruane: To ask the Secretary of State for Health what assessment he has made of the level of availability of mindfulness-based treatment for repeat episode depression in each health authority. [142467]

Norman Lamb: Information from the Improving Access to Psychological Therapies regional teams shows that Mindfulness Cognitive Behavioural Therapy is available to some extent in all 10 strategic health authority areas.

Diabetes

Dan Jarvis: To ask the Secretary of State for Health whether his Department has any plans to reward GPs for ensuring all the nine basic diabetes tests are delivered for patients with diabetes. [142997]

Dr Poulter: The national Quality and Outcomes Framework (QOF) provides additional reward to general practitioner (GP) practices for how well they care for patients based on their performance against a number of agreed indicators.

Since 2004, GPs have been paid incentives for providing the nine basic checks on people with diabetes. Performance and patient care have improved considerably as a result of this. However, more needs to be done to ensure that everyone with diabetes receives all of the nine basic checks.

The National Institute for Health and Clinical Excellence (NICE) is responsible for reviewing the evidence base for QOF indicators. The NHS Medical Director, Sir Bruce Keogh, has asked NICE to consider a composite indicator measuring the proportion of patients receiving all nine of the processes.

Food: Contamination

Mary Creagh: To ask the Secretary of State for Health how many food sample tests have been conducted by (a) the Food Standards Agency and (b) local authorities acting on behalf of the Food Standards Agency in each of the last five years. [142896]

Anna Soubry: Information about the type and number of samples taken by Food Standards Agency (FSA) staff is set out in the annual reports of the Implementation of the UK National Control Plan since 2007. The FSA also publishes the reports of occasional surveys of foods, which help judge the effectiveness of food law regulation/to inform negotiations with the European Commission, monitor trends and assess risks. These reports can all be found on the FSA website.

The FSA requires local authorities by means of the Food Law Code of Practice to have risk-based sampling programmes in place. The FSA also provides funding for local authorities to carry out sampling as part of an annual National Co-ordinated Sampling Programme. The FSA annual monitoring of local authority sampling in four of the last five years is set out in the following

12 Feb 2013 : Column 665W

table. The complete data for local authority sampling and analysis carried out for 1 April 2012 to 31 March 2013 is not yet available.

 Total analysesTotal samples

2008-09

133,054

98,561

2009-10

121,964

105,556

2010-11

110,108

92,122

2011-12

92,181

78,653

Heart Diseases

Meg Munn: To ask the Secretary of State for Health (1) if he will direct the National Specialised Commissioning Team to release all reports prepared for the Advisory Group for National Specialised Services and the National Specialised Commissioning Group which relate to (a) paediatric cardiac surgery, (b) cardiac transplants and (c) extra-corporeal membrane oxygenation; [142988]

(2) if he will direct the National Specialised Commissioning Team to publish the report by Professor Michael Arthur, Chairman of the Advisory Group for National Specialised Services, to the Joint Committee of Primary Care Trusts meeting on 23 April 2012. [142989]

Anna Soubry: The papers prepared by the Advisory Group for National Specialised Services (AGNSS) and the National Specialised Commissioning Group relating to (a) paediatric cardiac surgery, (b) cardiac transplants and (c) extra-corporeal membrane oxygenation, together with the paper from AGNSS to the Joint Committee of Primary Care Trusts of 23 April, have all been released following Freedom of Information requests.

Home Care Services

Mr Jim Cunningham: To ask the Secretary of State for Health (1) how many people are dependent on home care providers; [142429]

(2) if he will take steps to ensure that private companies that provide home care have in place contingency plans for when they may be unable to provide essential care; [142430]

Norman Lamb: We are informed by the NHS Information Centre for Health and Social Care that, in 2011-12—the latest available figures—the number of service users in England receiving home care provided or arranged by local councils was 517,000. This is a provisional figure; final, validated data will be published on 15 February 2013.

Information on the numbers of people in England who arrange and fund their own home care Is not collected centrally.

If a local authority arranges or provides care, it is responsible for ensuring that the care meets the needs of service users, whether it provides care directly or via contracting with an independent sector provider. If such a provider is unable to deliver the service, the local authority would be responsible for ensuring suitable alternative provision.

12 Feb 2013 : Column 666W

A local authority has a duty under section 47(1) of the NHS and Community Care Act 1990 to assess a person's needs when it appears to the authority, that the person may be in need of community care services. Local authorities may, depending on the result of an assessment, have a duty to provide or arrange care to meet a person's assessed needs.

A local authority will not normally provide or arrange care for self funders—people who are able to afford to pay for their own care. However, it may arrange, but not necessarily pay for, care for self funders who lack capacity or the ability to do so and have nobody to act on their behalf.

The Government are currently consulting on a new system of market oversight in adult social care, which would offer greater protections for individuals who rely upon care and support services, including home care. The plans include measures to:

strengthen and clarify the responsibility of local authorities in the event of failure;

oversee financial performance of providers;

challenge business models to make sure they can support the delivery of quality care services;

ensure businesses develop plans to recover from financial distress;

provide the regulator with information to develop contingency plans with local authorities for continuing care in the event of a failure; and

coordinate and communicate with local authorities and relevant parties in the event of failure to ensure people's care and support needs continue to be met.

The consultation closes on 1 March. The consultation document, “Market Oversight in Adult Social care”, has been placed in the Library and is available at:

http://caringforourfuture.dh.gov.uk/2012/12/03/provider-failure/

Horses: Phenylbutazone

Huw Irranca-Davies: To ask the Secretary of State for Health how many tests for the presence of phenylbutazone in horses have been carried out by (a) the Food Standards Agency and (b) any other Government-funded agency in each of the last six months. [142295]

Anna Soubry: The information requested is shown in the following table.

  Samples collected and tested by the FSA for presence of phenylbutazoneSamples collected and tested by other Government funded agencies for presence of phenylbutazone

2012

July

12

6

2012

August

37

4

2012

September

16

6

2012

October

7

2012

November

7

2012

December

1

    

2013

January

73

6

Notes: 1. Some samples collected in January are currently still being tested. 2. The samples collected and tested by other Government funded agencies have been collected on behalf of the Veterinary Residues Committee as part of the Veterinary Residues Statutory Survey.

12 Feb 2013 : Column 667W

Huw Irranca-Davies: To ask the Secretary of State for Health how many horses in UK abattoirs have tested positive for phenylbutazone in each of the last three years. [142453]

Anna Soubry: The information requested is shown in the following table.

 Total number of samples collected for testing of phenylbutazone at UK AbattoirsNumber of compliant (negative) resultsNumber of non-compliant (positive) results

2010

60

55

5

2011

79

78

1

2012

158

149

9

Note: The samples collected in 2010 and 2011 where collected as part of the Veterinary Residues Statutory Survey and the samples collected in 2012 where collected as part of both the Veterinary Residues Statutory Survey and the Food Standards Agency Survey.

Hospitals: Infectious Diseases

Andrew Rosindell: To ask the Secretary of State for Health how many cases of hospital-acquired infections have been recorded in each of the last 10 years. [142435]

Dr Poulter: The Government have made it a key priority that the national health service should take a zero tolerance approach to all health are associated infections, with every hospital performing at the level of the very best. In fact, Methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia and Clostridium difficile (C. difficile) infections are at their lowest levels since mandatory reporting for each was introduced.

Although the Health Protection Agency does not routinely collect comprehensive data on all hospital-acquired infections, it does collect data on the following infections: MRSA bacteraemia, C. difficile infection and Methicillin sensitive Staphylococcus aureus (MSSA) bacteraemia by acute NHS trust. The data on these infections are contained in the following table, for the years for which figures are available.

Trust apportioned reports by organism and financial year
OrganismApril 2007 to March 2008April 2008 to March 2009April 2009 to March 2010April 2010 to March 2011April 2011 to March 2012

Clostridium difficile infection(1)

33,442

19,927

13,220

10,417

7,670

MRSA bacteraemia

(2)

1,606

1,004

688

473

MSSA bacteraemia

(2)

(2)

(2)

(2)

2,835

(1) C. difficile infection data is for individuals aged two years and over. (2) Not collected.

Data are correct as of 18 April 2012. Trust apportioned C. difficile data are available from financial year 2007-08 to 2011-12; MRSA bacteraemia from 2008-09 to 2011-12, and MSSA bacteraemia for 2011-12 only (as surveillance started in 2011). Prior to these time periods the appropriate information was not collected to allow the data to be categorised in this way.

Andrew Rosindell: To ask the Secretary of State for Health what steps he is taking to promote greater cleanliness in hospitals and prevent the spread of hospital acquired infections. [142585]

12 Feb 2013 : Column 668W

Dr Poulter: The NHS Constitution commits the national health service to ensure that services are provided in a:

'clean and safe environment that is fit for purpose, based on national best practice'.

Providers of NHS funded care must also secure and maintain registration with the Care Quality Commission (CQC) against a range of essential standards of safety and quality. These include requirements in relation to cleanliness and infection control. The Department has published guidance (the ‘Code of Practice for health and adult social care on the prevention and control of infections and related guidance’) to support providers in demonstrating how they comply with this standard.

A clean safe environment is essential for effective infection prevention and control and instils confidence in patients who often use cleanliness as a proxy for other quality indicators. The Government have made it a key priority that the NHS should take a zero tolerance approach to all health care associated infections, with every hospital performing at the level of the very best. In fact, Methicillin-resistant Staphylococcus aureus bloodstream infections and Clostridium difficile infections are at their lowest levels since mandatory reporting for each was introduced.

By all recent measures, hospital cleanliness has also improved across the NHS and these improvements have been noticed by patients. The CQC's in-patient survey is a key indicator—the most recent results (May 2012) showed the highest ever levels of satisfaction with the cleanliness of hospital wards, toilets and bathrooms.

A new system of patient led assessments of the care environment (PLACE) is to be introduced in April 2013 to support local improvement activity across a range of non-clinical services including cleanliness in hospitals providing NHS funded care. The process will require providers formally to respond to the findings of the assessment teams.

Human Papillomavirus

Mr Blunt: To ask the Secretary of State for Health what steps he is taking to monitor the possibility that those pre-exposed to vaccine relevant types of human papillomavirus may be at greater risk of developing cervical cancer if vaccinated. [142233]

Anna Soubry: Human papillomavirus (HPV) vaccines are inactivated vaccines. They do not contain live organisms and cannot cause the disease against which they protect.

The incidence of cervical cancer is monitored over time through the Office for National Statistics. The HPV immunisation programme is eventually expected to significantly lower cases of cervical cancer.

Mr Blunt: To ask the Secretary of State for Health what steps his Department is taking to monitor the emergence of new and more virulent human papilloma virus types replacing those suppressed by Gardasil and Cervarix. [142234]

Anna Soubry: The Department provides funding to the Health Protection Agency (HPA) to support evaluation of the impact of the human papillomavirus (HPV) immunisation programme on HPV infection and disease. The HPA is conducting surveillance of HPV infection, using opportunistic sources of anonymised residual

12 Feb 2013 : Column 669W

clinical specimens, to monitor the frequency of type-specific genital HPV infections in England. As well as monitoring the impact of immunisation on the vaccine-types, this surveillance will, in due course, report on the frequency of infection with HPV types that are not in current vaccines in order to inform assessment of cross-protection against these types and any emergence of these types.

Mr Blunt: To ask the Secretary of State for Health (1) what steps his Department is taking to ensure new medical conditions occurring after human papilloma virus vaccination are examined as possible vaccine reactions; [142235]

(2) what his assessment is on whether patient information accurately portrays potential adverse outcomes from human papilloma virus vaccines. [142236]

Norman Lamb: The Medicines and Healthcare products Regulatory Agency (MHRA) is responsible for monitoring the safety of all medicines including vaccines used in the United Kingdom and has robust systems in place to achieve this. Healthcare professionals, patients and carers are asked to submit reports of suspected adverse reactions to medicines and vaccines via the Yellow Card scheme. The MHRA uses data from the Yellow Card scheme alongside evaluation of data from clinical studies, medical literature and use of statistical and epidemiological tools to assess possible risks. The MHRA works very closely with regulatory authorities from other countries and seeks independent expert advice from the UK's Commission on Human Medicines (CHM) when evaluating potential new risks or medical conditions suspected to be side effects of vaccines and medicines. When there is sufficient evidence that a vaccine or medicines may be associated with a new risk, regulatory action is taken to ensure that the balance of benefits and risks remains positive.

As with all vaccines and medicines, the product information for Ceryarix and Gardasil human papillomavirus (HPV) vaccines, including the Summary of Product Characteristics (SPC) for healthcare professionals and patient information leaflet (PIL) for patients, is kept under continual review to ensure it reflects current robust evidence on the possible side effects of the vaccines. Possible side effects are listed in the product information where there is sufficient evidence that there is at least a possible causal association with the vaccine. The current product information for both HPV vaccines accurately reflects what is known about the safety of the HPV vaccines at this time.

ICT

Steve McCabe: To ask the Secretary of State for Health what the (a) start date, (b) planned completion date, (c) expected completion date, (d) planned cost and (e) expected cost was of each information technology project with a value in excess of £1 million undertaken by his Department and its executive agencies since 2010; and if he will make a statement. [142364]

Dr Poulter: Information technology (IT) projects are those projects initiated by the IT functions of the Department and its agencies to deploy improved, upgraded and replacement IT infrastructure and services to their

12 Feb 2013 : Column 670W

organisations. Business change or service improvement projects which may contain an IT element, even where the IT component is in excess of £1 million have been excluded as these are not classed as IT projects.

The Medicines and Healthcare products Regulatory Agency have commissioned two projects with a value exceeding £1 million.

Year of approvalProjectPlanned costs (£)Expected costsStart datePlanned completion dateExpected completion date

2012

Modernise IT

1,510,000

On budget

August 2012

May 2013

May 2013

2010

RBI

2,265,000

On budget

August 2010

February 2013

February 2013

The Department has commissioned one project with a value exceeding £1 million. Connecting for Health have commissioned no IT projects in excess of £1 million.

Year of approvalProjectPlanned costs (£)Expected costsStart datePlanned completion dateExpected completion date

2011

IMS3/Open Service

10,000,000

On budget

January 2012

March 2013

June 2013

Meat: Contamination

Huw Irranca-Davies: To ask the Secretary of State for Health when the Food Standards Agency will announce the test results on meat withdrawn from sale. [142294]

Anna Soubry: Immediately after the results of the Food Safety Authority of Ireland's survey were issued, the Food Standards Agency (FSA) launched an investigation into how a number of beef products on sale in the United Kingdom and Republic of Ireland came to contain some traces of horse and pig DNA. The results of these investigations are being published on the agency's website at:

www.food.gov.uk

At a meeting on 4 February, the FSA agreed with the food industry to publish the results of industry testing of meat products, to provide a clearer picture of standards in the food chain. The results will also be made publicly available. The outcome of this meeting was published on our website at:

www.food.gov.uk/news-updates/news/2013/feb/fsa-statement

The FSA will also publish the results from the UK-wide study of food authenticity on equine and porcine DNA in processed meat products available at retail, catering and wholesale businesses, including wholesale businesses supplying schools and hospitals. The study is already under way and results will be published in April 2013.

In addition, on 7 February, the FSA announced it is demanding a more comprehensive meat testing programme from food businesses. The tests will be for the presence of significant levels of horse meat in all beef products, such as beef burgers, meatballs and lasagne. The deadline for these results to be provided to the FSA is 15 February.

Mary Creagh: To ask the Secretary of State for Health what samples from (a) schools, (b) hospitals and (c) prisons will be taken by the Food Standards

12 Feb 2013 : Column 671W

Agency during its inquiry into undeclared equine and porcine DNA in meat products. [142895]

Anna Soubry: As part of the published four-point action plan, the Food Standards Agency is working closely with the Department for Environment, Food and Rural Affairs, the devolved rural affairs departments and local authorities on a United Kingdom-wide study of food authenticity on horse and pig DNA in comminuted beef products.

The sampling protocol for the survey specifies that local authorities should take samples from wholesale and catering food businesses, particularly those supplying schools and hospitals. This is also likely to cover wholesalers supplying food to other institutional organisations such as prisons.

Medical Equipment

Tessa Munt: To ask the Secretary of State for Health (1) pursuant to the answer of 22 January 2013, Official Report, column 213W, how much of the £300 million fund has been spent to date; what medical equipment such funding has been provided; and which hospitals acquired the equipment; [142288]

(2) pursuant to the answer of 31 January 2013, Official Report, column 913W, on radiotherapy, whether all the funding used by NHS trusts to purchase 12 radiotherapy machines came from the £28.35 million; [142352]

(3) pursuant to the answer of 31 January 2013, Official Report, column 913W, on radiotherapy, whether large single medical equipment purchases for which funds have been raised entirely from charitable donations are exempt from the NHS Supply Chain charge of between one and three per cent; [142353]

(4) pursuant to the answer of 31 January 2013, Official Report, column 913W, on radiotherapy, whether NHS Supply Chain purchased all 20 Linacs at a discounted price; and what plans NHS Supply Chain has to purchase more. [142355]

Dr Poulter: The total expenditure from the £300 million fund by NHS Supply Chain (NHSSC) with suppliers to date (February 2013) is £114 million.

The total expenditure by national health service trusts with NHSSC made through the fund to date (February 2013) is £65 million.

Information on the modality of medical equipment the funding has provided is provided in List 1. Information on which hospital trusts have acquired the equipment is provided in List 2.

List 1

Modality

Anaesthesia

Angiography

Bladder Scanner

Bladder Scanners

CT Scanners

Flexible Endoscopy

Linac

Mammography

MII

Mobile X-Ray

12 Feb 2013 : Column 672W

MRI

Patient Monitoring

Static X-Ray

Ultrasound

X-Ray

List 2

Gloucestershire Hospitals NHS FT

Clatterbridge Centre for Oncology NHS FT

Barts Health NHS trust

North Cumbria University Hospitals NHS Trust

Tameside Hospital NHS FT

Walsall Healthcare NHS Trust

Pennine Acute Hospitals NHS Trust

University College London Hospitals NHS FT

Hinchingbrooke Health Care NHS Trust

East Lancashire Hospitals NHS Trust

Yeovil District Hospital NHS FT

The Royal Marsden NHS FT

Central London Community Healthcare NHS Trust

Croydon Health Services NHS Trust

Colchester Hospital University NHS FT

University Hospitals Birmingham NHS FT

Heart of England NHS FT

Barnsley Hospital NHS FT

Hull and East Yorkshire Hospitals NHS Trust

University Hospitals of Morecambe Bay NHS FT

Royal National Hospital for Rheumatic Diseases NHS FT

Chelsea and Westminster Hospital NHS FT

Doncaster and Bassetlaw Hospitals NHS FT

Rotherham, Doncaster and South Humber NHS FT

Gateshead Health NHS FT

Oxford University Hospitals NHS Trust

Abertawe Bro Morgannwg University LHB

Luton And Dunstable Hospital NHS FT

Great Western Hospitals NHS FT

Taunton and Somerset NHS FT

Barnet and Chase Farm Hospitals NHS Trust

Medway NHS FT

Calderdale and Huddersfield NHS FT

Halton and St Helens PCT

South Warwickshire NHS FT

Bradford Teaching Hospitals NHS FT

Worcestershire Acute Hospitals NHS Trust

Solent NHS Trust

Aintree University Hospitals NHS FT

Imperial College Healthcare NHS Trust

Plymouth Hospitals NHS Trust

York Teaching Hospital NHS FT

North West London Hospitals NHS Trust

Leeds Teaching Hospitals NHS Trust

Royal Liverpool and Broadgreen University Hospitals NHS Trust

South Eastern Health and Social Care

Alder Hey Children's NHS FT

Wirral University Teaching Hospital NHS FT

Nottingham University Hospitals NHS Trust

Dartford and Gravesham NHS Trust

Lancashire Teaching Hospitals NHS FT

Cwm Taf LHB

12 Feb 2013 : Column 673W

University Hospital of South Manchester NHS FT

Guy's and St Thomas' NHS FT

East Cheshire NHS Trust

Central Manchester University Hospitals NHS FT

Wrightington, Wigan and Leigh NHS FT

Northern Heath and Social Care Trust

Ashford and St Peter's Hospitals NHS FT

St George's Healthcare NHS Trust

Poole Hospital NHS FT

Bolton NHS FT

Barking, Havering and Redbridge University Hospitals NHS Trust

University Hospital of North Staffordshire NHS Trust

University Hospitals of Leicester NHS Trust

Isle of Wight NHS PCT

Southend University Hospital NHS FT

Betsi Cadwaladr University LHB

Warrington and Halton Hospitals NHS FT

Royal National Orthopaedic Hospital NHS Trust

East Kent Hospitals University NHS FT

North Middlesex University Hospital NHS Trust

University Hospitals Bristol NHS FT

Birmingham Women's NHS FT

Portsmouth Hospitals NHS Trust

Maidstone and Tunbridge Wells NHS Trust

Leeds PCT

Brighton and Sussex University Hospitals NHS Trust

NHS Wales Shared Services Partnership

South Tees Hospitals NHS FT

Frimley Park Hospital NHS FT

South Devon Healthcare NHS FT

Belfast Health and Social Care Trust

Mid Yorkshire Hospitals NHS Trust

Leicestershire County and Rutland PCT

Northern Lincolnshire and Goole Hospitals NHS FT

Royal Free Hampstead NHS Trust

Papworth Hospital NHS FT

Mid Staffordshire NHS FT

Bristol and Weston Purchasing Consortium—North Bristol NHS Trust

Sherwood Forest Hospitals NHS FT

Royal Cornwall Hospitals NHS Trust

Birmingham Children's Hospital NHS FT

East and North Hertfordshire NHS Trust

Newcastle PCT

Northampton General Hospital NHS Trust

Liverpool Heart and Chest NHS FT

Great Ormond Street Hospital for Children NHS Trust

Aneurin Bevan LHB

King's College Hospital NHS FT

Buckinghamshire Healthcare NHS Trust

Royal United Hospital Bath NHS Trust

County Durham and Darlington NHS FT

North Tees and Hartlepool NHS FT

East Sussex Healthcare NHS Trust

Derby Hospitals NHS FT

Leicester City PCT

Hampshire Hospitals NHS FT

12 Feb 2013 : Column 674W

Sheffield Teaching Hospitals NHS FT

The Newcastle Upon Tyne Hospitals NHS FT

Kettering General Hospital NHS FT

James Paget University Hospitals NHS FT

Hywel Dda LHB

Basildon and Thurrock University Hospitals NHS FT

Torbay Care Trust

Shrewsbury and Telford Hospital NHS Trust

West Hertfordshire Hospitals NHS Trust

Derbyshire Community Health Services NHS Trust

Norfolk and Norwich University Hospitals NHS FT

North Staffordshire Combined Healthcare NHS Trust

Homerton University Hospital NHS FT

Burton Hospitals NHS FT

Epsom and St Helier University Hospitals NHS Trust

Cambridge University Hospitals NHS FT

The Hillingdon Hospitals NHS FT

Royal Brompton and Harefield NHS FT

Lewisham Healthcare NHS Trust

Liverpool Women's NHS FT

The Princess Alexandra Hospital NHS Trust

Heatherwood and Wexham Park Hospitals NHS FT

Peterborough And Stamford Hospitals NHS FT

Chesterfield Royal Hospital NHS FT

Maidstone and Tunbridge Wells Dorset County Hospital NHS FT

Kingston Hospital NHS Trust

Royal Surrey County Hospital NHS FT

Southern Health and Social Care Trust

Western Health and Social Care Trust

RAF High Wycombe

With regard to funding used by the NHS to purchase radiography machines, the NHSSC have purchased 20 Linac machines, to the value of £28.5 million, for onward sale to the NHS. Eight remain unsold to date. The 12 NHS trust purchasers have paid NHSSC £18,564,845 to purchase these machines for their own use and to individual trust specifications.

Regarding whether funds raised entirely from charitable donations are exempt from NHSSC charges, NHSSC charge this fee directly to the supplier and not the trust.

Finally, with regard to the purchasing of the 20 Linac machines, we can confirm that all 20 were bought at a discounted rate. NHSSC are in the process of discussing further deals with suppliers.

NHS: Finance

Andrew George: To ask the Secretary of State for Health (1) how many patient attendance episodes at each acute hospital received (a) no payment reward and (b) lower than tariff payment award in each of the last five years for which records are available; [142447]

(2) if he will provide the (a) market forces factor figures and (b) actual tariff payments made to each (a) NHS trust, (b) foundation trust, (c) private provider of services and (d) other providers of services for each procedure for which a tariff is applicable. [142449]

Dr Poulter: The Department does not hold centrally information on how many patient attendance episodes received no payment reward or lower than tariff payment

12 Feb 2013 : Column 675W

award nor does the Department hold centrally information on the actual tariff payments made to providers for each procedure for which a tariff is applicable.

A document showing the market forces factor (MFF) for NHS trusts, foundation trusts and primary care trusts has been placed in the Library. For non-NHS providers, the MFF used is that of the NHS trust or foundation trust nearest to the location where the care was delivered.

Andrew George: To ask the Secretary of State for Health (1) what payments will be made to NHS bodies which provide emergency services per (a) treatment provided and (b) emergency admission in 2013-14; [142448]

(2) what payment arrangements are made to acute trusts which provide (a) emergency department, (b) accident and emergency services and (c) minor injury facilities for each service (i) on a per patient basis and (ii) if there is a cap on payments to those emergency services; [142450]

(3) what the per patient payment-by-results payment was for each patient attendance at an emergency department in each of the last five years for which records are available. [142451]

Dr Poulter: NHS bodies which provide emergency services will receive a tariff payment for the attendance at accident and emergency (A&E) and, where appropriate, a further payment for non-elective activity if the patient

12 Feb 2013 : Column 676W

is then admitted. Payments for emergency services will depend on the level of activity, the national tariff which applies to that activity plus the market forces factor (MFF) payment which is unique to that organisation. There are also a number of rules within the Payment by Results (PbR) system which will influence payments to providers such as the marginal rate emergency tariff, non-payment for some emergency readmissions, the short stay emergency adjustment and long stay payments.

The Department does not collect information on the payments made to providers for each patient attendance at an emergency department. While the Department publishes the national tariff, the rules and the MFF, it does not collect information on the actual payments to trusts.

The tariffs which were set for A&E attendances between 2008-09 and 2012-13, and the proposed tariff for A&E attendances in 2013-14, are shown in the tables.

Between 2011-12 and 2013-14, non-24 hour A&E units and minor injury units (MIUs) are eligible for the lowest tariff only.

Tariffs for non-elective admissions and the rules around payment are published annually on the Department's website(1).

(1) Tariff prices are set out in the tariff information spreadsheet:

www.dh.gov.uk/health/2012/02/confirmation-pbr-arrangements/

and the rules are explained in the PbR Guidance for 2012-13:

www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_132654

National Tariff—Accident and Emergency Tariff (2011-12 to 2013-14)
Healthcare resource group codeHealthcare resource group nameBand (used in 2012-13 and 2011-12)2013-14(1) (£)2012-13 (£)2011-12 (£)

VB01Z

Any investigation with category 5 treatment

1

237

235

183

VB02Z

Category 3 investigation with category 4 treatment

1

210

235

183

VB03Z

Category 3 investigation with category 1-3 treatment

2

164

151

133

VB04Z

Category 2 investigation with category 4 treatment

2

139

151

133

VB05Z

Category 2 investigation with category 3 treatment

2

130

151

133

VB06Z

Category 1 investigation with category 3-4 treatment

3

102

81

78

VB07Z

Category 2 investigation with category 2 treatment

4

119

112

110

VB08Z

Category 2 investigation with category 1 treatment

4

110

112

110

VB09Z

Category 1 investigation with category 1-2 treatment

3

78

81

78

VB10Z

Dental Care

5

59

54

52

VB11Z(2)

No investigation with no significant treatment

5

58

54

52

(1) Banding is not applied in 2013-14. (2) It is expected that ail activity taking place within non-24 hour departments and MIUs attract price forVB11Z.
National Tariff—Accident and Emergency Tariff (2008-09 to 2010-11)
Healthcare resource group codeHealthcare resource group nameA&E tariff name/ band2010-11 (£)2009-10 (£)2008-09 (£)

U06

Attendance disposal Invalid for grouping

No Payment

0

0

0

DOA

Dead on Arrival

Standard

87

80

75

V01

High cost imaging (Died/ Admitted)

High

117

109

102

V02

High cost imaging (Referred / Discharged)

High

117

109

102

12 Feb 2013 : Column 677W

12 Feb 2013 : Column 678W

V03

Other high cost investigation (Died / Admitted)

High

117

109

102

V04

Other high cost investigation (Referred / Discharged)

High

117

109

102

V05

Low cost investigation (Died / Admitted)

Standard

87

80

75

V06

Low cost investigation (Referred / Discharged)

Standard

87

80

75

V07

No investigation (Died / Admitted)

Minor

59

59

56

V08

No investigation (Referred / Discharged)

Minor

59

59

56

V100MC

Non-24 hour A&E Department / Casualty Department

Minor

59

59

56

V100MI(1)

Discrete Minor Injuries Unit

Minor

59

59

56

(1) It is expected that all activity taking place within non-24 hour departments and MIUs attract price for V100MI.

Organs: Donors

Rehman Chishti: To ask the Secretary of State for Health how many and what proportion of people who died whilst waiting for an organ donation in each of the last 10 years were (a) white, (b) Asian and Asian British, (c) black and black British, (d) Chinese and oriental, (e) mixed and (f) other. [142901]

Anna Soubry: The information requested is shown in the following table.

Number and proportion of United Kingdom patients who have died while waiting for an organ transplant (2003 to 2012 by ethnic origin)
  Year of death
Ethnic origin 2003200420052006200720082009201020112012Total

White

Number

473

511

522

523

571

540

616

578

533

434

5,301

 

%

84.8

85.3

82.3

84.9

85.5

84.2

82.6

84.0

81.2

81.3

83.6

Asian/Asian British

Number

50

46

71

56

61

58

86

67

76

61

632

 

%

9.0

7.7

11.2

9.1

9.1

9.0

11.5

9.7

11.6

11.4

10.0

Black/Black British

Number

27

29

33

23

26

32

32

30

32

26

290

 

%

4.8

4.8

5.2

3.7

3.9

5.0

4.3

4.4

4.9

4.9

4.6

Chinese/Oriental

Number

2

3

4

6

1

2

8

5

6

5

42

 

%

0.4

0.5

0.6

1.0

0.1

0.3

1.1

0.7

0.9

0.9

0.7

Mixed

Number

2

1

0

3

1

1

2

0

1

4

15

 

%

0.4

0.2

0.0

0.5

0.1

0.2

0.3

0.0

0.2

0.7

0.2

Other

Number

4

9

4

5

8

8

2

8

8

4

60

 

%

0.7

1.5

0.6

0.8

1.2

1.2

0.3

1.2

1.2

0.7

0.9

Not recorded

Number

4

7

6

3

3

2

4

2

2

1

34

Total

 

562

606

640

619

671

643

750

690

658

535

6,374

Note: Table includes cases where patient was removed from transplant list due to deterioration and then died. Percentages are of those patients in each year where ethnic origin is recorded. Source: NHS Blood and Transplant

Post-Traumatic Stress Disorder

Andrew Rosindell: To ask the Secretary of State for Health what steps his Department is taking to ensure that members of the emergency and armed services are given access to the most advanced treatments for post- traumatic stress disorder. [142436]

Norman Lamb: Ambulance services have robust processes in place for supporting staff with post traumatic stress disorder (PTSD) and other similar post-incident disorders. All services have Occupational Health departments which invariably provide the counselling services or, through sub-contracting arrangements, buy in the specialised resources needed as required. Ambulance services have 24 hour, seven-day access to these services.

All fire and rescue authorities will have access to occupational health services who will arrange the appropriate treatment and support as necessary.

The provisions for welfare of members of the police (and this would include officers and staff suffering from PTSD and related disorders) would be a matter for the individual police force.

The majority of mental health treatment for members of the armed forces is provided by members of the Defence Medical Services (DMS), who have extensive experience in psychological treatments for mental health problems in general and psychological injury in particular. The DMS monitors the latest advances and developments in treatment in order to ensure .that service personnel receive the most effective and efficient interventions.

12 Feb 2013 : Column 679W

In providing treatment for PTSD, DMS mental health professionals follow the guidelines and standards set by the National Institute for Health and Clinical Excellence (NICE). NICE has assessed that Trauma Focussed Cognitive Behavioural Therapy and Eye Movement Desensitisation and Reprocessing are known to be effective in treating PTSD, and both of these are available as required in the network of military-run Departments of Community Mental Health in the United Kingdom and Germany.

Andrew Rosindell: To ask the Secretary of State for Health what steps his Department is taking to ensure the early diagnosis of post-traumatic stress disorder in members of the emergency services. [142495]

Dr Poulter: Individual national health service trusts are responsible for the health and wellbeing of their staff including ensuring those with post-traumatic stress disorder (PTSD) get an early diagnosis and the care they need.

Ambulance services have robust processes in place for supporting staff with PTSD and other similar post-incident disorders. All services have occupational health departments which invariably provide the counselling services or, through sub-contracting arrangements, buy in the

12 Feb 2013 : Column 680W

specialised resources needed as required. Ambulance services have 24 hour, seven-day access to these services.

Following the Department's comprehensive review of NHS staff health and wellbeing, there is now extensive advice and guidance available to support trusts via the Health, Work and Wellbeing pages on NHS Employers' website at:

www.nhsemployers.org/healthyworkplaces/pages/home-healthy.aspx

Andrew Rosindell: To ask the Secretary of State for Health how many individuals currently employed in the emergency services have received treatment for post-traumatic stress disorder in the last five years. [142549]

Dr Poulter: This information is not held centrally.

Sexually Transmitted Infections

Mr Blunt: To ask the Secretary of State for Health what the rate of infection has been of (a) Chlamydia and (b) all other sexually transmitted diseases in (i) girls and (ii) boys under 18 years old in each year since 2005. [142232]

Anna Soubry: The information available is shown in the following table:

Rates of selected sexually transmitted infections (STIs), per 100,000 population, diagnosed in England, 2005-11
STIAge groupGender2005200620072008200920102011

Chlamydia

<15

Male

3.8

4.8

4.5

5.0

4.0

3.2

3.5

  

Female

45.5

47.4

49.5

53.8

43.0

42.2

42.4

  

Total

24.1

25.5

26.4

28.8

23.0

22.2

22.5

 

15 to 19

Male

420.9

448.6

504.8

954.5

1,077.0

1,127.8

1,039.1

  

Female

1,174.0

1,139.5

1,215.2

2,956.5

3,276.7

3,268.0

3,027.2

  

Total

787.8

783.2

849.1

1,943.9

2,162.1

2,172.0

2,008.3

 

All ages

Male

183.0

196.8

213.3

280.7

293.7

298.6

297.9

  

Female

202.2

198.6

211.5

401.2

430.9

422.6

412.1

  

Total

192.8

197.7

212.4

343.9

365.5

362.4

356.5

          

Gonorrhoea

<15

Male

1.8

1.4

0.9

0.6

0.6

0.5

0.3

  

Female

9.2

6.4

8.8

7.1

7.2

6.5

7.2

  

Total

5.4

3.8

4.8

3.8

3.8

3.4

3.7

 

15 to 19

Male

87.8

84.9

90.0

74.9

74.7

68.1

76.4

  

Female

124.9

116.7

127.7

123.8

121.2

118.0

120.8

  

Total

105.9

100.3

108.3

98.7

97.6

92.4

98.0

 

All ages

Male

50.6

48.5

46.1

38.8

42.4

45.1

58.2

  

Female

19.9

19.8

21.3

19.8

20.1

19.6

22.6

  

Total

34.9

33.9

33.5

29.1

31.2

32.2

40.1

          

Herpes (first episode)

<15

Male

0.3

0.2

0.0

0.8

0.3

0.2

0.8

  

Female

5.2

5.1

9.1

10.3

8.9

7.5

9.2

  

Total

2.7

2.6

4.4

5.4

4.5

3.8

4.9

 

15 to 19

Male

29.8

31.5

37.1

41.4

41.2

45.5

44.9

  

Female

133.4

156.9

190.3

208.4

201.2

214.0

221.1

  

Total

80.3

92.2

111.4

122.6

119.0

127.2

130.4

 

All ages

Male

27.2

29.9

36.1

39.9

42.5

45.2

46.3

  

Female

41.4

45.7

55.6

61.2

63.4

68.5

72.6

  

Total

34.4

37.9

46.0

50.7

53.1

57.0

59.6

          

12 Feb 2013 : Column 681W

12 Feb 2013 : Column 682W

Syphilis

<15

Male

0.4

0.0

0.0

0.2

0.0

0.0

0.0

  

Female

1.1

0.2

0.3

0.5

0.0

0.0

0.2

  

Total

0.8

0.1

0.2

0.3

0.0

0.0

0.1

 

15 to 19

Male

4.0

3.3

2.5

2.8

3.7

3.2

4.0

  

Female

2.2

3.2

2.7

1.7

3.2

2.0

1.3

  

Total

3.1

3.2

2.6

2.3

3.5

2.6

2.7

 

All ages

Male

10.8

10.8

11.1

9.9

9.8

9.1

10.2

  

Female

2.0

1.7

1.6

1.4

1.3

1.1

1.1

  

Total

6.3

6.1

6.3

5.6

5.5

5.1

5.6

          

Warts (first episode)

<15

Male

4.1

3.9

4.0

2.2

1.0

1.8

1.4

  

Female

17.4

17.9

20.7

22.4

22.9

16.2

14.7

  

Total

10.6

10.7

12.2

12.0

11.6

8.8

7.9

 

15 to 19

Male

222.3

231.1

257.2

274.3

275.4

257.3

252.4

  

Female

605.8

634.8

689.4

720.6

700.1

639.4

619.1

  

Total

409.1

426.6

466.7

491.2

482.3

442.8

430.2

 

All ages

Male

145.3

148.5

158.2

162.3

164.1

158.3

160.5

  

Female

124.0

126.5

136.8

141.9

136.6

130.6

131.2

  

Total

134.5

137.3

147.3

151.9

150.3

144.4

145.6

Notes: 1. Data are sourced from genitor-urinary medicine (GUM) clinic KC60 returns (2005-08) and GUM clinic GUMCAD returns (2009-11). GUM clinic Chlamydia data are supplemented with data from the National Chlamydia Screening Programme (NCSP) and ‘Non-NCSP/Non-GUM’ services (2008-11) for those aged 15 to 24. 2. Numbers of diagnoses are estimated where GUM clinic data are unavailable. 3. Data presented follow calendar years (January to December), not financial years (April to March). 4. Data represent the number of diagnoses reported and not the number of people diagnosed. 5. Data represent STI diagnoses among people accessing services located in England, i.e. data may include people who are resident in England; Wales, Scotland, Northern Ireland or abroad. 6. Rates for 2011 have been calculated using Office for National Statistics population estimates for 2010. 7. Data on diagnoses reported with an unknown gender may be included in the diagnosis total. 8. Age group ‘<15’ includes those aged 13 to 14 only.